Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) & Anor v Sandoz Ltd
The trade mark registration lacks the clarity, precision, specificity, and uniformity required by Article 4 of EUTMR, leaving the public uncertain as to the protected sign and giving Glaxo an unfair competitive advantage. The mark is therefore invalid.
- Parties
- Claimant/appellant: Glaxo Wellcome UK Ltd (t/a Allen & Hanburys); Claimant/appellant: Glaxo Group Ltd; Defendant/respondent: Sandoz Ltd
- Jurisdiction
- England and Wales
- Judgment Date
- 10 May 2017
- Procedural Posture
- Civil Appeal / Appeal From Summary Judgment in High Court
- Outcome
- Appeal dismissed; summary judgment for respondent upheld.
- Legal Topics
- EU Trade Mark Regulation, Graphical Representation, Colour Marks, Precision and Clarity in Registration
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Glaxo Wellcome UK Ltd (t/a Allen & Hanburys)
Claimant/appellant
Glaxo Group Ltd
Claimant/appellant
Sandoz Ltd
Defendant/respondent
Procedural Posture
Civil Appeal / Appeal From Summary Judgment in High Court
Legal Issues
- 1 Whether the EU trade mark registration is invalid for lack of clarity, precision, and uniformity under Article 4 of EUTMR
- 2 Interaction between pictorial representation and verbal description in colour per se marks
- 3 Whether the mark gives an unfair competitive advantage due to uncertainty
Ratio Decidendi
The trade mark registration lacks the clarity, precision, specificity, and uniformity required by Article 4 of EUTMR, leaving the public uncertain as to the protected sign and giving Glaxo an unfair competitive advantage. The mark is therefore invalid.
Court Disposition
Appeal dismissed; summary judgment for respondent upheld.
Orders
- Trade Mark declared invalid.
- Claim for infringement dismissed.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment